Hui Miao

Hui Miao

Auto-generated profile, based on publicly available information

Hui Miao

Key Laboratory of Pathobiology (Yanbian University), State Ethnic Affairs Commission, Yanji, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2022 in Science Advances
Verified
Journal Article
Open access
HMHui Miao
Hui Miao
FWFan Wu
Fan Wu
YLYu Li
Yu Li
CQChenyu Qin
Chenyu Qin
YZYongyun Zhao
Yongyun Zhao
LLLing Li
Ling Li
Understanding how long noncoding RNAs (lncRNAs) cooperate with splicing factors (SFs) in alternative splicing (AS) control is fundamental to human biology and disease. We show that metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a well-documented AS-implicated lncRNA, regulates AS via two SFs, polypyrimidine tract–binding protein 1 (PTBP1) and PTB-associated SF (PSF). MALAT1 stabilizes the interaction between PTBP1 and PSF, thereby forming a functional module that affects a network of AS events. The MALAT1-stabilized PTBP1/PSF interaction occurs in multiple cellular contexts; however, the functional module, relative to MALAT1 only, has more dominant pathological significance in hepatocellular carcinoma. MALAT1 also stabilizes the PSF interaction with several heterogeneous nuclear ribonucleoparticle proteins other than PTBP1, hinting a broad role in AS control. We present a model in which MALAT1 cooperates with distinct SFs for AS regulation and pose that, relative to analyses exclusively performed for lncRNAs, a comprehensive consideration of lncRNAs and their binding partners may provide more information about their biological functions.

11 January 2024 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
LZLei Zhao
Lei Zhao
HMHui Miao
Hui Miao
MQMingqi Quan
Mingqi Quan
SWShuhao Wang
Shuhao Wang
YZYu Zhang
Yu Zhang
JPJUNJIE PIAO
JUNJIE PIAO

19 September 2023 in Science Signaling
Verified
Journal Article
Closed access
DLDanxiu Li
Danxiu Li
XWXin Wang
Xin Wang
HMHui Miao
Hui Miao
HLHao Liu
Hao Liu
MPMaogui Pang
Maogui Pang
XZXiaodi Zhao
Xiaodi Zhao
Alternative splicing regulates gene expression and functional diversity and is often dysregulated in human cancers. Here, we discovered that the long noncoding RNA (lncRNA) MIR99AHG regulated alternative splicing to alter the activity of a chromatin remodeler and promote metastatic behaviors in colorectal cancer (CRC). MIR99AHG was abundant in invasive CRC cells and metastatic tumors from patients and promoted motility and invasion in cultured CRC cells. MIR99AHG bound to and stabilized the RNA splicing factor PTBP1, and this complex increased cassette exon inclusion in the mRNA encoding the chromatin remodeling gene SMARCA1 . Specifically, MIR99AHG altered the nature of PTBP1 binding to the splice sites on intron 12 of SMARCA1 pre-mRNA, thereby triggering a splicing switch from skipping to including exon 13 to produce the long isoform, SMARCA1-L. SMARCA1, but not SMARCA1-L, suppressed invadopodia formation, cell migration, and invasion. Analysis of CRC samples revealed that the abundance of MIR99AHG transcript positively correlated with that of SMARCA1-L mRNA and PTBP1 protein and with poor prognosis in patients with CRC. Furthermore, TGF-β1 secretion from cancer-associated fibroblasts increased MIR99AHG expression in CRC cells. Our findings identify an lncRNA that is induced by cues from the tumor microenvironment and that interacts with PTBP1 to regulate alternative splicing, potentially providing a therapeutic target and predictive biomarker for metastatic CRC.